Results
PharmaFluidics acquired by Thermo Fisher Scientific
PharmaFluidics is now part of Thermo Fisher Scientific, the world leader in serving science. This acquisition brings about new opportunities to create greater value and strengthens its ability to fulfill Thermo Fisher’s mission, which is to enable customers to make the...
Read more
SOPHIA: deploying robots for improved ergonomy
VUB research by research group Human Physiology and Sports Physiotherapy (MFYS) shows that more than half of European workers have long-term muscle and bone complaints. Innovative robots, cobots and exoskeletons that can relieve that work and make it healthier are therefore a ma...
Read more
VUB Green Energy Park and Photonics in De Standaard Innovation Special
Read the articles about the large-scale living lab Green Energy Park and the one-stop-shop for photonics in De Standaard. We teamed up with Maarten Messagie and Thierry Coosemans of the VUB research group Evergi and Nathalie Debaes of B-PHOT.
Read more
VUB and EsoBiotec ready to transform cell therapy cancer treatments
EsoBiotec, a recently founded biotech company, announces a EUR 6 million pre-series A round comprised of non-dilutive funding from the Walloon Government combined with seed investments from venture capitalist Thuja Capital and regional funding agencies SRIW Life Sciences and Sambrinvest.
Read more
Smart Village Lab helps accelerate energy transition in Flanders and Europe
The Smart Village Lab is the first physical realisation of the Green Energy Park, which was founded by the VUB and the UZ Brussel and will investigate how living in the future can become smart, sustainable and energy-efficient.Via an innovative, safe and lifelike living lab, Green Energy Park m...
Read more
Confo Therapeutics enters clinical stage with drug for neuropathic pain
Confo Therapeutics is a rising star in Belgium, featured on several local and international lists of up-and-coming biotechs. The company, launched in 2015 as a VUB/VIB spin-off is now taking the big step from the preclinical to the clinical stage with a GPCR drug for neuropathic pain.
Read more
VUB's expertise in computer-generated holography
The department of Electronics and Informatics (ETRO) of the VUB and imec built-up a reputation in the domain of computer-generated holography. This technology is key to providing high-end media content for holographic display and printing.
Read more
Radical new technology to diagnose and monitor can help millions of diabetics
More than 500 million people worldwide suffer from diabetes. Today the monitoring process is expensive and time consuming and not all patients can be reached.
Read more
From demolition towards preservation: A paradigm shift for Brussels building sector
Why are buildings being demolished and how can we influence decision making processes of building teams? How do narratives on the city and architectural taste influence whether a building will be demolished?
Read more
VUB invests in applied research with IOF funding
The Industrial Research Fund (IOF) is an earmarked University Association Fund that is annually fed with a block grant from the Flemish Government.
Read more